Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Estradiol with progestogen
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Estradiol valerate 1mg / Medroxyprogesterone 2.5mg tablets
0604011L0AABEBE
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | 277 |
|
Estradiol valerate 2mg / Medroxyprogesterone 5mg tablets
0604011L0AABGBG
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | 241 |
|
Estradiol valerate 1mg / Medroxyprogesterone 5mg tablets
0604011L0AABFBF
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | 159 |
|
FemSeven Sequi patches
0604011L0BVAABI
|
FemSeven Sequi | Estradiol with progestogen | Endocrine System | 75 |
|
Angeliq 1mg/2mg tablets
0604011L0BZAABK
|
Angeliq | Estradiol with progestogen | Endocrine System | 17 |
|
Cyclo-Progynova 2mg tablets
0604011L0BCABAC
|
Cyclo-Progynova | Estradiol with progestogen | Endocrine System | 10 |
|
Clinorette tablets
0604011L0CBAAA0
|
Clinorette | Estradiol with progestogen | Endocrine System | 9 |
|
Estradiol 1mg / Drospirenone 2mg tablets
0604011L0AABKBK
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | 6 |
|
Generic Femoston 2/10mg tablets
0604011L0AAAMAM
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | 2 |
|
Generic Novofem tablets
0604011L0AABHBH
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | 2 |
|
Generic Elleste Duet 1mg tablets
0604011L0AAAWAW
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | 1 |
|
Generic Femoston 1/10mg tablets
0604011L0AAAPAP
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | 1 |
|
Adgyn Combi tablets
0604011L0BSAAAI
|
Adgyn Combi | Estradiol with progestogen | Endocrine System | No data available |
|
Climagest 1mg tablets
0604011L0BGAAAH
|
Climagest | Estradiol with progestogen | Endocrine System | No data available |
|
Climagest 2mg tablets
0604011L0BGABAI
|
Climagest | Estradiol with progestogen | Endocrine System | No data available |
|
Climesse tablets
0604011L0BMAAAR
|
Climesse | Estradiol with progestogen | Endocrine System | No data available |
|
Cyclo-Progynova 1mg tablets
0604011L0BCAAAB
|
Cyclo-Progynova | Estradiol with progestogen | Endocrine System | No data available |
|
Estracombi TTS patches
0604011L0BFAAAG
|
Estracombi | Estradiol with progestogen | Endocrine System | No data available |
|
Estradiol 30microg/Norethist 95microg/24hours ptch
0604011L0AABPBP
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | No data available |
|
Estradiol 40microg/24hours ptch and Dydrogesterone 10mg tab
0604011L0AAAUAU
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | No data available |
|
Estradiol 40microg/Norethist 130microg/24hours ptch
0604011L0AABNBN
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | No data available |
|
Estradiol 50microg/24hours ptch and Norethist 1mg tab
0604011L0AAAJAJ
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | No data available |
|
Estradiol 50microg/24hours ptch and Norethist acet 1mg tab
0604011L0AABBBB
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | No data available |
|
Estradiol 80microg/24hours ptch and Dydrogesterone 10mg tab
0604011L0AAAQAQ
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | No data available |
|
Estradiol valerate 2mg / Norethisterone 700microgram tablets
0604011L0AAARAR
|
Estradiol with progestogen | Estradiol with progestogen | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.